PTGS2 and wet macular degeneration: Collectively, the data on COX-2 inhibition suggest no beneficial effects on wet AMD but potential aggravation in the progression of dry AMD, thereby conflicting with the idea of COX-2-induced and MDSC-mediated neovascularization.